This study showed that over a 3-month period the use of sensor-augmented insulin-pump therapy with the threshold-suspend feature reduced nocturnal hypoglycemia, without increasing glycated hemoglobin values (NEJM)
Diabetes News Service
This study showed that over a 3-month period the use of sensor-augmented insulin-pump therapy with the threshold-suspend feature reduced nocturnal hypoglycemia, without increasing glycated hemoglobin values (NEJM)
A Glycosmedia iPhone/iPad App is available FREE from the iTunes store.
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
This site complies with the HONcode standard for trustworthy health information: verify here.
Website by Wired up Wales